Attitudes towards glaucoma genetic risk assessment in unaffected individuals

Author:

Hollitt Georgina LORCID,Siggs Owen MORCID,Ridge Bronwyn,Keane Miriam CORCID,Mackey David AORCID,MacGregor StuartORCID,Hewitt Alex WORCID,Craig Jamie EORCID,Souzeau EmmanuelleORCID

Abstract

ABSTRACTIntegrating polygenic risk scores (PRS) into healthcare has the potential to stratify an individual’s risk of glaucoma across a broad population. Glaucoma is the most common cause of irreversible blindness worldwide, therefore effective screening for glaucoma endorsed by the population is highly important. This study assessed the attitude of unaffected individuals towards PRS testing for glaucoma, and sought to identify factors associated with interest in testing. We surveyed 418 unaffected individuals including those with a first-degree relative with glaucoma (n=193), those who had a recent eye examination (n=117), and general members of the community (n=108). Overall, 71.3% indicated an interest in taking a polygenic risk test for glaucoma. Interest was more likely in those who believed glaucoma to be a severe medical condition (OR 14.58, 95%CI (1.15-185.50), p=0.039), those concerned about developing glaucoma (OR 4.37, 95%CI (2.32-8.25), p<0.001), those with an intention to take appropriate measures regarding eye health (OR 2.39, 95%CI (1.16-4.95), p=0.019), and those preferring to know if considered to be at-risk or not (OR 4.52, 95%CI (2.32-8.83), p<0.001). These findings represent a valuable assessment of general public interest in glaucoma polygenic risk testing, which will be integral to the implementation and uptake of novel PRS based tests into clinical practice.

Publisher

Cold Spring Harbor Laboratory

Reference37 articles.

1. Primary open-angle glaucoma

2. Genetic Risk of Primary Open-angle Glaucoma

3. The number of people with glaucoma worldwide in 2010 and 2020

4. Prevalence of Open-angle Glaucoma in Australia

5. National Health and Medical Research Council. NHMRC Guidelines for the Screening, Prognosis, Diagnosis, Management and Prevention of Glaucoma. 2010:1–181. https://www.nhmrc.gov.au/about-us/publications/guidelines-screening-prognosis-diagnosis-management-and-prevention-glaucoma.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3